Use of a combination of angiotensin-converting enzyme inhibitor

Details Use of a combination of angiotensin-converting enzyme inhibitor Use of a combination of angiotensin-converting enzyme inhibitor

1991-11-26

1993-08-17

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514356, 514412, 514423, A61K 3147, A61K 3144, A61K 3140

Patent

active

052369331

ABSTRACT:
The invention relates to the prevention and therapy of proteinuria by administration of a combination of ACE inhibitor and calcium antagonist.

REFERENCES:
patent: 4129571 (1978-12-01), Ondetti et al.
patent: 4154960 (1979-05-01), Ondetti et al.
patent: 4294832 (1981-09-01), Yoneda et al.
patent: 4344949 (1982-08-01), Hoefle et al.
patent: 4350633 (1982-09-01), Kim et al.
patent: 4350704 (1982-09-01), Hoefle et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4374847 (1983-02-01), Gruenfield
patent: 4454292 (1984-06-01), Kim et al.
patent: 4470972 (1984-09-01), Gold et al.
patent: 4703038 (1987-10-01), Garthoff et al.
patent: 5098910 (1992-03-01), Becker et al.
CA 114(5):35665v, Tolins et al. (1990).
T Unger, et al., Handbook of Experimental Pharmacology, vol. 93, pp. 379-481 (1989).
Journal of Cardiovascular Pharmacology, vol. 16, No. 6, (Dec. 1990), pp. 924-930, H. J. Kloke et al.
Journal of Cardiovascular Pharmacology, vol. 10, No. S10, (1987), pp. 167-169, B. Jackson et al.
AM. Heart Journal, vol. 116, No. 6/1, (1988), pp. 1591-1606, J. B. Kostis.
Z. Kardiol., vol. 77, No. S3, (1988), pp. 73-88, D. Klaus.

Affiliated with

Also associated with

Rating

Use of a combination of angiotensin-converting enzyme inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a combination of angiotensin-converting enzyme inhibitor , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a combination of angiotensin-converting enzyme inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2243928